(Q43160887)

15 November 2017

title

New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited (English)

1 reference

toxic epidermal necrolysis

15 November 2017

main subject

1 reference

Philippe Paquet

1

1 reference

15 November 2017

Gérald E Piérard

series ordinal

2

1 reference

15 November 2017

publication date

1 March 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

33

1 reference

15 November 2017

issue

3

1 reference

15 November 2017

page(s)

189-212

1 reference

Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Heterotopic ossification related to toxic epidermal necrolysis in a patient with Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Physiopathology and treatment of severe drug eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Drug metabolism in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532540-000000000-00000

Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series

21 January 2018

1 reference

12 December 2020

Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin

1 reference

12 December 2020

Glutathione deficiency and human immunodeficiency virus infection

1 reference

12 December 2020

Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study

1 reference

12 December 2020

The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy

1 reference

12 December 2020

Epidermal calprotectin in drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry

1 reference

12 December 2020

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)

1 reference

12 December 2020

T cell immune responses to haptens. Structural models for allergic and autoimmune reactions

1 reference

12 December 2020

Antiretroviral-induced toxiderma in HIV-infected patients

1 reference

12 December 2020

Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience

1 reference

12 December 2020

Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

12 December 2020

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

1 reference

12 December 2020

Toxic epidermal necrolysis and hemolytic uremic syndrome after allogeneic stem-cell transplantation

1 reference

12 December 2020

Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients

1 reference

12 December 2020

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?

1 reference

12 December 2020

Factor-XIIIa-positive dendrocytes in drug-induced toxic epidermal necrolysis (Lyell's syndrome): paradoxical activation in skin and rarefaction in lymph nodes

1 reference

12 December 2020

Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression

1 reference

12 December 2020

Toxic epidermal necrolysis in a mother and fetus

1 reference

12 December 2020

Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management

1 reference

12 December 2020

Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes

1 reference

12 December 2020

More than two different bacterial species isolated from blood of toxic epidermal necrolysis patients significantly increase mortality

1 reference

12 December 2020

Intestinal involvement in drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases.

1 reference

12 December 2020

SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center

1 reference

12 December 2020

Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin.

1 reference

12 December 2020

T-cell involvement in drug-induced acute generalized exanthematous pustulosis

1 reference

12 December 2020

Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin

1 reference

12 December 2020

Toxic epidermal necrolysis following bone marrow transplantation

1 reference

12 December 2020

Glutathione-S-transferase pi expression in toxic epidermal necrolysis: a marker of putative oxidative stress in keratinocytes

1 reference

12 December 2020

Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns

1 reference

12 December 2020

Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature

1 reference

12 December 2020

Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.

1 reference

12 December 2020

Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children

1 reference

12 December 2020

Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage.

1 reference

12 December 2020

Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection

1 reference

12 December 2020

Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

1 reference

12 December 2020

Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis

1 reference

12 December 2020

Long-term consequences of toxic epidermal necrolysis in children

1 reference

12 December 2020

Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs.

1 reference

12 December 2020

Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group

1 reference

12 December 2020

Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany

1 reference

12 December 2020

Involvement of macrophages in the pathology of toxic epidermal necrolysis

1 reference

12 December 2020

HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese.

1 reference

12 December 2020

Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study

1 reference

12 December 2020

Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption

1 reference

12 December 2020

Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab

1 reference

12 December 2020

Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors

1 reference

12 December 2020

Is apoptosis mediated by reactive oxygen species?

1 reference

12 December 2020

Burn center care for patients with toxic epidermal necrolysis.

1 reference

12 December 2020

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

12 December 2020

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients

1 reference

12 December 2020

Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy

1 reference

12 December 2020

A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis

1 reference

12 December 2020

Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.

1 reference

12 December 2020

Toxic epidermal necrolysis in a pregnant, HIV-infected woman

1 reference

12 December 2020

Toxic epidermal necrolysis. Treatment with pentoxifylline

1 reference

12 December 2020

Early pathological features of the cornea in toxic epidermal necrolysis

1 reference

12 December 2020

Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis

1 reference

12 December 2020

The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum

1 reference

12 December 2020

Intravenous immunoglobulins in the treatment of severe drug eruptions

1 reference

12 December 2020

Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome

1 reference

12 December 2020

Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions

1 reference

12 December 2020

Toxic epidermal necrolysis associated with treatment for preterm labor

1 reference

12 December 2020

Toxic epidermal necrolysis complicated by multiple intestinal ulcers

1 reference

12 December 2020

Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor

1 reference

12 December 2020

Plasma exchange; a promising treatment for toxic epidermal necrolysis with AIDS.

1 reference

12 December 2020

Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management

1 reference

12 December 2020

Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider

1 reference

12 December 2020

Toxic epidermal necrolysis in oncologic patients

1 reference

12 December 2020

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

1 reference

12 December 2020

Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes

1 reference

12 December 2020

Toxic epidermal necrolysis: does immunoglobulin make a difference?

1 reference

12 December 2020

The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective

1 reference

12 December 2020

Erythema multiforme due to Mycoplasma pneumoniae infection in two children

1 reference

12 December 2020

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

1 reference

12 December 2020

AQUACEL Ag in the treatment of toxic epidermal necrolysis (TEN).

1 reference

12 December 2020

The drug hypersensitivity syndrome: what is the pathogenesis?

1 reference

12 December 2020

Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association

1 reference

12 December 2020

Successful treatment of toxic epidermal necrolysis with calcium sodium alginate fiber

1 reference

12 December 2020

Etanercept for toxic epidermal necrolysis

1 reference

12 December 2020

An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods.

1 reference

12 December 2020

Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome. Contribution of perforin-positive cell infiltration

1 reference

12 December 2020

Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases

1 reference

12 December 2020

Adverse drug reaction monitoring: doing it the French way

1 reference

12 December 2020

Treatment of extensive toxic epidermal necrolysis in children

1 reference

12 December 2020

Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis

1 reference

12 December 2020

Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens?Johnson syndrome/toxic epidermal necrolysis

1 reference

12 December 2020

Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis.

1 reference

12 December 2020

Toxic epidermal necrolysis associated with Klebsiella pneumoniae sepsis

1 reference

12 December 2020

Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis

1 reference

12 December 2020

Ileal involvement in toxic epidermal necrolysis (Lyell syndrome)

1 reference

12 December 2020

Severe cutaneous reactions associated with the use of human immunodeficiency virus medications

1 reference

12 December 2020

Mitochondria and apoptosis

1 reference

12 December 2020

Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children

1 reference

12 December 2020

Renal involvement in toxic epidermal necrolysis

1 reference

12 December 2020

Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Oral cyclosporin and alopecia areata

1 reference

12 December 2020

Long-term follow-up of patients treated for toxic epidermal necrolysis

1 reference

12 December 2020

High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.

1 reference

12 December 2020

Immune modulating nutrition support for a patient with severe toxic epidermal necrolysis

1 reference

12 December 2020

Medical genetics: a marker for Stevens-Johnson syndrome

1 reference

12 December 2020

A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

1 reference

12 December 2020

Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis

1 reference

12 December 2020

Dermatological and Ophthalmological Sequels in Toxic Epidermal Necrolysis

1 reference

12 December 2020

Transient verrucous hyperplasia after toxic epidermal necrolysis

1 reference

12 December 2020

Glutathione deficiency is associated with impaired survival in HIV disease

1 reference

12 December 2020

SCORTEN overestimates mortality in the setting of a standardized treatment protocol.

1 reference

12 December 2020

Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative beta-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability

1 reference

12 December 2020

Toxic epidermal necrolysis: a review and report of the successful use of Biobrane for early wound coverage.

1 reference

12 December 2020

Toxic epidermal necrolysis following Yersinia enterocolitica infection

1 reference

12 December 2020

Toxic epidermal necrolysis and graft vs. host disease: a clinical spectrum but a diagnostic dilemma

1 reference

12 December 2020

[Persistant mucosal ulcerations: a rare complication of toxic epidermal necrolysis]

1 reference

12 December 2020

Regulatory function of factor-XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus-host reaction. A hypothesis

1 reference

12 December 2020

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment

1 reference

12 December 2020

Acute and chronic respiratory complications of toxic epidermal necrolysis

1 reference

12 December 2020

Acute onset Hodgkin's disease following Lyell's syndrome

1 reference

12 December 2020

Disseminated intravascular coagulation associated with toxic epidermal necrolysis (Lyell's syndrome)

1 reference

12 December 2020

Vulvovaginal involvement in toxic epidermal necrolysis: a retrospective study of 40 cases

1 reference

12 December 2020

A 10-year experience with toxic epidermal necrolysis

1 reference

12 December 2020

Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine

1 reference

12 December 2020

Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response

1 reference

12 December 2020

An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression

1 reference

12 December 2020

Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors

1 reference

12 December 2020

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

1 reference

12 December 2020

Vulval adenosis associated with toxic epidermal necrolysis

1 reference

12 December 2020

Haematological disturbances and immune mechanisms in toxic epidermal necrolysis

1 reference

12 December 2020

Heterotopic ossification as a complication of toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis: a systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids

1 reference

12 December 2020

Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern

1 reference

12 December 2020

A semisynthetic bilaminar skin substitute used to treat pediatric full-body toxic epidermal necrolysis: wraparound technique in a 17-month-old girl.

1 reference

12 December 2020

Cyclophosphamide in the treatment of toxic epidermal necrolysis.

1 reference

12 December 2020

Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center.

1 reference

12 December 2020

Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital

1 reference

12 December 2020

Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system

1 reference

12 December 2020

Toxic epidermal necrolysis (TEN) and Stevens–Johnson syndrome (SJS): Experience with high-dose intravenous immunoglobulins and topical conservative approach

1 reference

12 December 2020

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

1 reference

12 December 2020

Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.

1 reference

12 December 2020

Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis

1 reference

12 December 2020

Skin coverage with Biobrane biomaterial for the treatment of patients with toxic epidermal necrolysis

1 reference

12 December 2020

Fatal toxic epidermal necrolysis following reexposure to phenytoin: a case report

1 reference

12 December 2020

Total antioxidant capacity and nuclear DNA damage in keratinocytes after exposure to H2O2.

1 reference

12 December 2020

Toxic epidermal necrolysis (Lyell syndrome): more than "acute skin failure"

1 reference

12 December 2020

Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome.

1 reference

12 December 2020

Sjögren-like syndrome after drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

A role for oxygen radicals as second messengers

1 reference

12 December 2020

Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding

1 reference

12 December 2020

Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

12 December 2020

The role of macrophage migration inhibition factor in toxic epidermal necrolysis

1 reference

12 December 2020

Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species

1 reference

12 December 2020

Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Toxic epidermal necrolysis after allogeneic haematopoietic stem cell transplantation

1 reference

12 December 2020

Penetration of keratinocyte-derived cytokines into basement membrane

1 reference

12 December 2020

HIV-1 in blister fluid of a patient with toxic epidermal necrolysis and AIDS

1 reference

12 December 2020

Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study

1 reference

12 December 2020

Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome

1 reference

12 December 2020

Biological skin covers in treatment of two cases of the Lyell's syndrome

1 reference

12 December 2020

Anticonvulsant hypersensitivity syndrome

1 reference

12 December 2020

Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis

1 reference

12 December 2020

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

12 December 2020

HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome.

1 reference

12 December 2020

Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples

1 reference

12 December 2020

Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis

1 reference

12 December 2020

Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases

1 reference

12 December 2020

Nitric oxide: cytotoxicity versus cytoprotection--how, why, when, and where?

1 reference

12 December 2020

Toxic epidermal necrolysis and systemic corticosteroids

1 reference

12 December 2020

Toxic epidermal necrolysis complicated by Mucor infection

1 reference

12 December 2020

Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome

1 reference

12 December 2020

Management of severe toxic epidermal necrolysis in children

1 reference

12 December 2020

Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis associated with severe hypocalcaemia, and treated with cyclosporin

1 reference

12 December 2020

Characterization of glutathione S-transferase in cultured human keratinocytes

1 reference

12 December 2020

Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement

1 reference

12 December 2020

The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients

1 reference

12 December 2020

Drug-induced toxic epidermal necrolysis treated with cyclosporin.

1 reference

12 December 2020

Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985

1 reference

12 December 2020

Toxic epidermal necrolysis following clindamycin treatment

1 reference

12 December 2020

Management of dysphagia in toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS)

1 reference

12 December 2020

SCORTEN: does it need modification?

1 reference

12 December 2020

In the pursuit of classifying severe cutaneous adverse reactions

1 reference

12 December 2020

Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis

1 reference

12 December 2020

Amniotic membrane in the surgical management of acute toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis: differential diagnosis of an epidermolytic dermopathy in a hematopoietic stem cell transplant recipient

1 reference

12 December 2020

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

1 reference

12 December 2020

Toxic epidermal necrolysis treated with N-acetylcysteine

1 reference

12 December 2020

Toxic epidermal necrolysis in systemic lupus erythematosus.

1 reference

12 December 2020

Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus

1 reference

12 December 2020

A marker for Stevens-Johnson syndrome ...: ethnicity matters

1 reference

12 December 2020

Clues to pathogenesis of toxic epidermal necrolysis

1 reference

12 December 2020

Cytokeratin15-positive basal epithelial cells targeted in graft-versus-host disease express a constitutive antiapoptotic phenotype

1 reference

12 December 2020

Nitric oxide: physiology, pathophysiology, and pharmacology

1 reference

12 December 2020

Lymphocyte transformation test in drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Ciclosporin use in toxic epidermal necrolysis

1 reference

12 December 2020

Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine

1 reference

12 December 2020

Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis?

1 reference

12 December 2020

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

1 reference

12 December 2020

Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

12 December 2020

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis

1 reference

12 December 2020

Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases

1 reference

12 December 2020

Evaluation of the potential role of cytokines in toxic epidermal necrolysis

1 reference

12 December 2020

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression

1 reference

12 December 2020

Intense pulsed light treatment of persistent facial hypermelanosis following drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Differential diagnosis of severe cutaneous drug eruptions

1 reference

12 December 2020

Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?

1 reference

12 December 2020

Skin allograft in the treatment of toxic epidermal necrolysis (TEN).

1 reference

12 December 2020

Toxic epidermal necrolysis: current evidence, practical management and future directions

1 reference

12 December 2020

Toxic epidermal necrolysis: an approach to management using cryopreserved allograft skin

1 reference

12 December 2020

T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells

1 reference

12 December 2020

Plasmapheresis in toxic epidermal necrolysis

1 reference

12 December 2020

Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.

1 reference

12 December 2020

Toxic epidermal necrolysis following morbilli-parotitis-rubella vaccination

1 reference

12 December 2020

HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.

1 reference

12 December 2020

Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

1 reference

12 December 2020

Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report

1 reference

12 December 2020

Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept

1 reference

12 December 2020

Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro/SS-A and a review of the published work

1 reference

12 December 2020

A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome

1 reference

12 December 2020

Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?

1 reference

12 December 2020

Cell-mediated immunologic mechanism and severity of TEN

1 reference

12 December 2020

Management of nonstaphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories

1 reference

12 December 2020

Differential pathomechanisms of epidermal necrolytic blistering diseases.

1 reference

12 December 2020

Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam

1 reference

12 December 2020

Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction.

1 reference

12 December 2020

High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis

1 reference

12 December 2020

Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children.

1 reference

12 December 2020

Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience

1 reference

12 December 2020

Hypopharyngeal stenosis and dysphagia complicating toxic epidermal necrolysis

1 reference

12 December 2020

Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects

1 reference

12 December 2020

Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis

1 reference

12 December 2020

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

1 reference

12 December 2020

Toxic epidermal necrolysis with adult respiratory distress syndrome.

1 reference

12 December 2020

Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center

1 reference

12 December 2020

Toxic epidermal necrolysis in a burns centre: a 6-year review

1 reference

12 December 2020

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

1 reference

12 December 2020

Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.

1 reference

12 December 2020

Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate

1 reference

12 December 2020

Outcome of patients with toxic epidermal necrolysis syndrome revisited

1 reference

12 December 2020

Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions

1 reference

12 December 2020

Cystic lesion of the parotid following drug-induced toxic epidermal necrolysis (Lyell's syndrome).

1 reference

12 December 2020

Severe hypothermia occurring during the course of toxic epidermal necrolysis in patients treated with air-fluidized beds

1 reference

12 December 2020

Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Alan Lyell and Lyell's syndrome

1 reference

12 December 2020

Genetic susceptibility to toxic epidermal necrolysis

1 reference

12 December 2020

Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese.

1 reference

12 December 2020

Toxic epidermal necrolysis in a burn patient complicated by acute pancreatitis

1 reference

12 December 2020

Cytokine removal during continuous hemofiltration in septic patients.

1 reference

12 December 2020

Toxic epidermal necrolysis with a rare long-term oral complication requiring surgical intervention

1 reference

12 December 2020

The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study

1 reference

12 December 2020

Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date

1 reference

12 December 2020

Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs

1 reference

12 December 2020

Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression

1 reference

12 December 2020

Intravenous ulinastatin therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis in pediatric patients. Three case reports

1 reference

12 December 2020

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

1 reference

12 December 2020

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

1 reference

12 December 2020

Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing

1 reference

12 December 2020

Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis

1 reference

12 December 2020

High-dose intravenous immunoglobulins in the treatment of toxic epidermal necrolysis: an Asian series

1 reference

12 December 2020

Immunohistochemical study of alpha, mu and pi class glutathione S transferase expression in malignant melanoma. MMM Group. Multidisciplinary Malignant Melanoma Group

1 reference

12 December 2020

Human leukocyte antigens and drug hypersensitivity

1 reference

12 December 2020

Toxic epidermal necrolysis. A step forward in treatment

1 reference

12 December 2020

Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review).

1 reference

12 December 2020

Treatment of toxic epidermal necrolysis with cyclosporin A

1 reference

12 December 2020

Plasmapheresis in severe drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases

1 reference

12 December 2020

Silicone gel treatment of extensive hypertrophic scarring following toxic epidermal necrolysis

1 reference

12 December 2020

Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement

1 reference

12 December 2020

Respiratory involvement in toxic epidermal necrolysis portends a poor prognosis that may not be reflected in SCORTEN

1 reference

12 December 2020

Toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis--a retrospective study

1 reference

12 December 2020

Free radicals and antioxidants: a personal view

1 reference

12 December 2020

Toxic epidermal necrolysis

1 reference

12 December 2020

Allergic and autoimmune reactions to xenobiotics: how do they arise?

1 reference

12 December 2020

Serum interleukin-13 levels are increased in patients with Stevens–Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme

1 reference

12 December 2020

Unusual Spindle Cell Squamous Carcinoma in a Renal Transplant Patient

1 reference

12 December 2020

10.2165/11532540-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

15 November 2017

1004504713

0 references

1 reference